Multiple Myeloma | Amrita Krishnan, MD

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Multiple Myeloma | Faculty Presentation 2: Chimeric Antigen Receptor T ‑ Cell Therapy, Bispecific Antibodies and Antibody ‑ Drug Conjugates — Amrita Krishnan, MD CME information and select publications